业界动态监管公开信息 · FDA
FDA授予lifileucel加速批准，用于不可切除或转移性黑色素瘤
FDA Drugs · 2026-11-10 05:50
摘要
FDA授予lifileucel加速批准，用于不可切除或转移性黑色素瘤
English
FDA grants accelerated approval to lifileucel for unresectable or metastatic melanoma
FDA grants accelerated approval to lifileucel for unresectable or metastatic melanoma